Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain
Clinical trial NCT02078089 · TERMINATED
Trial details
- NCT number
- NCT02078089
- Sponsor
- Costantine Albany
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-06
- Primary completion
- 2014-12-11
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.